117 related articles for article (PubMed ID: 1815508)
1. Localization of ligand binding regions of the human formyl peptide receptor.
Radel SJ; Genco RJ; De Nardin E
Biochem Int; 1991 Nov; 25(4):745-53. PubMed ID: 1815508
[TBL] [Abstract][Full Text] [Related]
2. The rabbit neutrophil N-formyl peptide receptor. cDNA cloning, expression, and structure/function implications.
Ye RD; Quehenberger O; Thomas KM; Navarro J; Cavanagh SL; Prossnitz ER; Cochrane CG
J Immunol; 1993 Feb; 150(4):1383-94. PubMed ID: 8432984
[TBL] [Abstract][Full Text] [Related]
3. Identification of a gene encoding for the human formyl peptide receptor.
De Nardin E; Radel SJ; Lewis N; Genco RJ; Hammarskjöld M
Biochem Int; 1992 Mar; 26(3):381-7. PubMed ID: 1627151
[TBL] [Abstract][Full Text] [Related]
4. The ligand binding site of the formyl peptide receptor maps in the transmembrane region.
Miettinen HM; Mills JS; Gripentrog JM; Dratz EA; Granger BL; Jesaitis AJ
J Immunol; 1997 Oct; 159(8):4045-54. PubMed ID: 9378994
[TBL] [Abstract][Full Text] [Related]
5. Characterization of N-formyl-methionyl-leucyl-phenylalanine receptors on human neutrophils. Effects of isolation and temperature on receptor expression and functional activity.
Tennenberg SD; Zemlan FP; Solomkin JS
J Immunol; 1988 Dec; 141(11):3937-44. PubMed ID: 2846695
[TBL] [Abstract][Full Text] [Related]
6. Removal of human polymorphonuclear leukocyte surface sialic acid inhibits reexpression (or recycling) of formyl peptide receptors. A possible explanation for its effect on formyl peptide-induced polymorphonuclear leukocyte chemotaxis.
Perez HD; Elfman F; Lobo E
J Immunol; 1987 Sep; 139(6):1978-84. PubMed ID: 3624873
[TBL] [Abstract][Full Text] [Related]
7. Immunochemical characterization of the formyl peptide receptor moieties on human neutrophils.
De Nardin E; Genco RJ
Hybridoma; 1991 Feb; 10(1):49-63. PubMed ID: 1709613
[TBL] [Abstract][Full Text] [Related]
8. Polymorphonuclear leukocytes cap a derivative of wheat germ agglutinin upon stimulation with formyl peptide and C5a but not leukotriene B4.
Kurrasch R; Elfman F; Perez HD
J Immunol; 1989 Sep; 143(6):1969-73. PubMed ID: 2550548
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
[TBL] [Abstract][Full Text] [Related]
10. A derivative of wheat germ agglutinin specifically inhibits formyl-peptide-induced polymorphonuclear leukocyte chemotaxis by blocking re-expression (or recycling) of receptors.
Perez HD; Elfman F; Lobo E; Sklar L; Chenoweth D; Hooper C
J Immunol; 1986 Mar; 136(5):1803-12. PubMed ID: 3753993
[TBL] [Abstract][Full Text] [Related]
11. Receptor binding kinetics and cellular responses of six N-formyl peptide agonists in human neutrophils.
Waller A; Sutton KL; Kinzer-Ursem TL; Absood A; Traynor JR; Linderman JJ; Omann GM
Biochemistry; 2004 Jun; 43(25):8204-16. PubMed ID: 15209517
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional characterization of the human formyl peptide receptor ligand-binding region.
Radel SJ; Genco RJ; De Nardin E
Infect Immun; 1994 May; 62(5):1726-32. PubMed ID: 8168934
[TBL] [Abstract][Full Text] [Related]
13. Regulation of C5a and formyl peptide receptor expression on human polymorphonuclear leukocytes.
Van Epps DE; Simpson S; Bender JG; Chenoweth DE
J Immunol; 1990 Feb; 144(3):1062-8. PubMed ID: 2295813
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
Perez HD; Elfman F; Chenoweth D; Hooper C
J Immunol; 1986 Mar; 136(5):1813-9. PubMed ID: 3753994
[TBL] [Abstract][Full Text] [Related]
15. Removal or oxidation of surface membrane sialic acid inhibits formyl-peptide-induced polymorphonuclear leukocyte chemotaxis.
Perez HD; Ong RR; Elfman F
J Immunol; 1985 Mar; 134(3):1902-8. PubMed ID: 2981927
[TBL] [Abstract][Full Text] [Related]
16. Antibodies directed to the chemotactic factor receptor detect differences between chemotactically normal and defective neutrophils from LJP patients.
DeNardin E; DeLuca C; Levine MJ; Genco RJ
J Periodontol; 1990 Oct; 61(10):609-17. PubMed ID: 2231227
[TBL] [Abstract][Full Text] [Related]
17. Subtle differences between human and rabbit neutrophil receptors shown by the secretagogue activity of constrained formyl peptides.
Dentino AR; Raj PA; De Nardin E
Arch Biochem Biophys; 1997 Jan; 337(2):267-74. PubMed ID: 9016822
[TBL] [Abstract][Full Text] [Related]
18. Significance of the extracellular domain and the carbohydrates of the human neutrophil N-formyl peptide chemotactic receptor for the signal transduction by the receptor.
Remes JJ; Petäjä-Repo UE; Tuukkanen KJ; Rajaniemi HJ
Exp Cell Res; 1993 Nov; 209(1):26-32. PubMed ID: 8224002
[TBL] [Abstract][Full Text] [Related]
19. N-terminus urea-substituted chemotactic peptides: new potent agonists and antagonists toward the neutrophil fMLF receptor.
Higgins JD; Bridger GJ; Derian CK; Beblavy MJ; Hernandez PE; Gaul FE; Abrams MJ; Pike MC; Solomon HF
J Med Chem; 1996 Mar; 39(5):1013-5. PubMed ID: 8676333
[No Abstract] [Full Text] [Related]
20. A mathematical model for ligand/receptor/G-protein dynamics and actin polymerization in human neutrophils.
Adams JA; Omann GM; Linderman JJ
J Theor Biol; 1998 Aug; 193(4):543-60. PubMed ID: 9745752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
